Biovie BIVI
NASDAQ BIVI
$1.95 +0.09 (+4.84%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biovie (BIVI) Goodwill & Intangibles (2016 - 2026)

Biovie (BIVI) posted Goodwill & Intangibles of $352019.0 for Q1 2026, down 14.01% sequentially from $409364.0 in Q4 2025, and down 39.45% YoY from $581396.0 in Q1 2025.

Biovie (BIVI) Goodwill & Intangibles (2016 - 2026) Analysis & Trends

Biovie has reported Goodwill & Intangibles for 11 years, with the latest figure at $352019.0 in Q1 2026.

  • Quarterly Goodwill & Intangibles fell 39.45% year-over-year to $352019.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $352019.0 (down 39.45% YoY) and the FY2025 annual result came in at $524052.0, down 30.44% from the prior year.
  • Goodwill & Intangibles eased to $352019.0 in Q1 2026 per BIVI's latest filing, from $409364.0 in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $1.3 million in Q1 2022 and troughed at $352019.0 in Q1 2026.
  • A 5-year average of $810773.4 and a median of $810773.0 in 2024 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2022 and 2026: Goodwill & Intangibles retreated 15.3% in 2022, then plunged 39.45% in 2026.
  • Over 5 years, Goodwill & Intangibles stood at $1.1 million in 2022, then declined by 20.9% to $868118.0 in 2023, then slipped by 26.42% to $638741.0 in 2024, then slumped by 35.91% to $409364.0 in 2025, then retreated by 14.01% to $352019.0 in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $352019.0, $409364.0, and $466708.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Biovie 14.17 Mn 14.17 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 345,711.00
Mar 31, 2026 352,019.00
Dec 31, 2025 409,364.00
Sep 30, 2025 466,708.00
Jun 30, 2025 524,052.00
Mar 31, 2025 581,396.00
Dec 31, 2024 638,741.00
Sep 30, 2024 696,085.00
Jun 30, 2024 753,429.00
Mar 31, 2024 810,773.00
Dec 31, 2023 868,118.00
Sep 30, 2023 925,462.00
Jun 30, 2023 982,806.00
Mar 31, 2023 1.04 Mn
Dec 31, 2022 1.10 Mn
Sep 30, 2022 1.15 Mn
Jun 30, 2022 1.21 Mn
Mar 31, 2022 1.27 Mn
Dec 31, 2021 1.33 Mn
Sep 30, 2021 1.38 Mn